Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery.
about
Construction of magnetic-carbon-quantum-dots-probe-labeled apoferritin nanocages for bioimaging and targeted therapy.Doxorubicin interactions with bovine serum albumin revealed by microdialysis with on-line laser-induced fluorescence detection at subpicogram level.Histological experimental study on the effect of stem cell therapy on adriamycin induced chemobrain.Synthetic and bioinspired cage nanoparticles for drug delivery.Apoferritin applications in nanomedicine.Apoferritin as an ubiquitous nanocarrier with excellent shelf life.Are engineered nano iron oxide particles safe? an environmental risk assessment by probabilistic exposure, effects and risk modeling.Capillary electrophoresis and nanomaterials - Part I: Capillary electrophoresis of nanomaterials.Fluorescence Characterization of Gold Modified Liposomes with Antisense N-myc DNA Bound to the Magnetisable Particles with Encapsulated Anticancer Drugs (Doxorubicin, Ellipticine and Etoposide).Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.Magnetic Nanoparticles: From Design and Synthesis to Real World Applications.Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin.Fluorescence resonance energy transfer between green fluorescent protein and doxorubicin enabled by DNA nanotechnology.ELISA-like Analysis of Cisplatinated DNA Using Magnetic Separation.
P2860
Q31132658-B50B8B9B-1F14-42AC-AA77-277FD45238D8Q35586789-F1E005E3-DA64-491B-9207-A2358CC4A3EAQ37425777-B56DA7D3-8FC4-4433-B165-0435B31D663BQ38254088-D3E423EC-8CF1-442A-A7A1-082E123F92B0Q38269129-3AC24D9A-03C4-4B59-9E96-B79C97FF9E5BQ38708389-9B3FBAA4-C908-47CD-AE36-86106FB9FE7BQ39249392-4CA2F943-4071-47D8-81E8-C5782BA306EBQ39407054-FC70F176-2B78-4128-B2EE-3727B68CB539Q39686527-5F3269F9-ACC1-441F-988B-5B1FD1BFFE48Q41183225-1E96C40E-54DE-4BB6-A2E7-28574412F9E0Q41667081-68141203-D6FE-4ECC-9010-705E26CEC08EQ45858764-E9418DFD-1661-42C6-AE30-0F83A1EFB253Q50450838-286D26E4-EDE1-4713-8931-64F88BB6DFB8Q55438409-401A321B-5E7B-49D2-AB42-C5CCE3889128
P2860
Apoferritin modified magnetic particles as doxorubicin carriers for anticancer drug delivery.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Apoferritin modified magnetic ...... for anticancer drug delivery.
@ast
Apoferritin modified magnetic ...... for anticancer drug delivery.
@en
Apoferritin modified magnetic ...... for anticancer drug delivery.
@nl
type
label
Apoferritin modified magnetic ...... for anticancer drug delivery.
@ast
Apoferritin modified magnetic ...... for anticancer drug delivery.
@en
Apoferritin modified magnetic ...... for anticancer drug delivery.
@nl
prefLabel
Apoferritin modified magnetic ...... for anticancer drug delivery.
@ast
Apoferritin modified magnetic ...... for anticancer drug delivery.
@en
Apoferritin modified magnetic ...... for anticancer drug delivery.
@nl
P2093
P2860
P356
P1476
Apoferritin modified magnetic ...... for anticancer drug delivery.
@en
P2093
Hoai Viet Nguyen
Iva Blazkova
Maja Stanisavljevic
Marie Stiborova
Marketa Vaculovicova
Pavel Kopel
Simona Dostalova
Tomas Eckschlager
P2860
P304
13391-13402
P356
10.3390/IJMS140713391
P407
P577
2013-06-27T00:00:00Z